KIR2DL2 Receptors
A KIR receptor that has specificity for HLA-C ANTIGENS. It is an inhibitory receptor that contains D1 and D2 extracellular immunoglobulin-like domains and a long cytoplasmic tail. It is similar in structure and function to the KIR2DL1 RECEPTORS and the KIR2DL3 RECEPTORS.
Also Known As:
Receptors, KIR2DL2; CD158b1 Antigen; KIR2DL2 Receptor; Killer Cell Immunoglobulin-like Receptor 2DL2; Natural Killer-Associated Transcript 6; Antigen, CD158b1; Killer Cell Immunoglobulin like Receptor 2DL2; Natural Killer Associated Transcript 6; Receptor, KIR2DL2; Antigens, CD158b1; CD158b1 Antigens
Networked: 9
relevant articles (0 outcomes,
1 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Rizzo, Roberta:
4 articles
(02/2022 - 10/2012)
|
2. | Bortolotti, Daria:
3 articles
(02/2022 - 06/2014)
|
3. | Rotola, Antonella:
3 articles
(02/2022 - 10/2012)
|
4. | Beltrami, Silvia:
2 articles
(02/2022 - 02/2022)
|
5. | Caselli, Elisabetta:
2 articles
(02/2022 - 10/2012)
|
6. | Gentili, Valentina:
2 articles
(02/2022 - 10/2012)
|
7. | Rizzo, Sabrina:
2 articles
(02/2022 - 02/2022)
|
8. | Schiuma, Giovanna:
2 articles
(02/2022 - 02/2022)
|
9. | Di Luca, Dario:
2 articles
(06/2014 - 10/2012)
|
10. | Baldi, Eleonora:
1 article
(02/2022)
|
Related Diseases
1. | Infections
|
2. | Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
|
3. | Virus Diseases (Viral Diseases)
|
4. | Kaposi Sarcoma (Kaposi's Sarcoma)
|
5. | Myocardial Infarction
01/01/2015
- " In myocardial infarction group, the mRNA expressions of six inhibitory receptors KIR2DL2, KIR3DL3, CD94, NKG2A, KLRB1, KLRG1, and eight activating receptors KIR2DS3, KIR2DS5, NKp30, NTB-A, CRACC, CD2, CD7 and CD96 were significantly down-regulated (P<0.05) compared with both angina patients and the controls. "
|
|
Related Drugs and Biologics